Please login to the form below

Not currently logged in
Email:
Password:

insuline glargine

This page shows the latest insuline glargine news and features for those working in and with pharma, biotech and healthcare.

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

The decision by the European Medicines Agency (EMA) moves the Lilly/ Boehringer insulin glargine biosimilar, known as LY2963016, one step closer to the market. ... Gwen Krivi, VP, Lilly Diabetes product development, said: "Long-acting insulin is a

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics